Cancer: Scientists aim to double survival within a decade | The Independent
Professor Kevin Harrington | The Royal Marsden
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Professor Kevin Harrington - The Institute of Cancer Research, London
My final lifeline" | The Biomedical Scientist Magazine of the IBMS
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
Professor Kevin Harrington - The Institute of Cancer Research, London
IReC - Meet the team | The Royal Marsden
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Skin cancer: below the surface | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Ahead of the curve | The Royal Marsden
Scientific Advisory Board – PsiVac
Cancer survival 'to double in 10 years' - PressReader
Cancer immunotherapy drug 'less toxic and prolongs life' - BBC News
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
Professor Kevin Harrington - The Institute of Cancer Research, London
GM herpes virus fights advanced cancers
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
Professor Kevin Harrington - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
